US Bancorp’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164 | Hold |
11
| – | – | ﹤0.01% | 4080 |
|
|
2025
Q1 | $129 | Sell |
11
-32
| -74% | -$375 | ﹤0.01% | 4113 |
|
|
2024
Q4 | $983 | Sell |
43
-69
| -62% | -$1.58K | ﹤0.01% | 3952 |
|
|
2024
Q3 | $4.7K | Sell |
112
-13
| -10% | -$546 | ﹤0.01% | 3578 |
|
|
2024
Q2 | $4.55K | Buy |
+125
| New | +$4.55K | ﹤0.01% | 3532 |
|
|
2024
Q1 | – | Sell |
-3,467
| Closed | -$67.2K | – | 4024 |
|
|
2023
Q4 | $67.2K | Hold |
3,467
| – | – | ﹤0.01% | 2516 |
|
|
2023
Q3 | $54.8K | Buy |
3,467
+1,250
| +56% | +$19.8K | ﹤0.01% | 2399 |
|
|
2023
Q2 | $36.8K | Hold |
2,217
| – | – | ﹤0.01% | 2640 |
|
|
2023
Q1 | $31K | Buy |
2,217
+1,167
| +111% | +$16.3K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $10.7K | Hold |
1,050
| – | – | ﹤0.01% | 3266 |
|
|
2022
Q3 | $13K | Hold |
1,050
| – | – | ﹤0.01% | 3257 |
|
|
2022
Q2 | $22K | Buy |
1,050
+500
| +91% | +$10.5K | ﹤0.01% | 2988 |
|
|
2022
Q1 | $21K | Buy |
+550
| New | +$21K | ﹤0.01% | 3032 |
|
|
2021
Q4 | – | Sell |
-8
| Closed | -$1K | – | 4139 |
|
|
2021
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 3950 |
|